Lineage Cell Therapeutics (LCTX) Change in Inventory (2010 - 2015)
Lineage Cell Therapeutics (LCTX) posted quarterly Change in Inventory of $81000.0 for Q4 2015, up 575.0% year-over-year from $12000.0 in Q4 2014, and up 325.0% quarter-over-quarter from -$36000.0 in Q3 2015.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Change in Inventory (2010 - 2015) Analysis & Trends
Lineage Cell Therapeutics' Change in Inventory history runs 6 years deep, the most recent figure standing at $81000.0 for Q4 2015.
- In Q4 2015, Change in Inventory rose 575.0% year-over-year to $81000.0; the TTM figure through Sep 2016 stood at $81000.0 (up 1250.0% YoY), while the FY2015 annual figure was $75000.0, down 13.79% from the prior year.
- Change in Inventory for Q4 2015 stood at $81000.0, up from -$36000.0 in the prior quarter.
- The five-year high for Change in Inventory was $117184.0 in Q4 2013, with the low at -$36000.0 in Q3 2015.
- The 5-year median for Change in Inventory is $1051.0 (2012), against an average of $12902.4.
- The sharpest annual moves came in 2013 and 2015: Change in Inventory surged 8064.47% in 2013, then tumbled 800.0% in 2015.
- Lineage Cell Therapeutics' Change in Inventory stood at -$9940.0 in 2011, then jumped by 83.37% to -$1653.0 in 2012, then soared by 7189.17% to $117184.0 in 2013, then slumped by 89.76% to $12000.0 in 2014, then jumped by 575.0% to $81000.0 in 2015.
- Business Quant data shows LCTX's Change in Inventory at $81000.0 in Q4 2015, -$36000.0 in Q3 2015, and -$3000.0 in Q2 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 132.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 47.15 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -280,000.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Lineage Cell Therapeutics | 270.71 Mn | 213.99 Mn | 1.07 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2015 | 81,000.00 |
| Sep 30, 2015 | -36,000.00 |
| Jun 30, 2015 | -3,000.00 |
| Mar 31, 2015 | 33,000.00 |
| Dec 31, 2014 | 12,000.00 |
| Sep 30, 2014 | -4,000.00 |
| Jun 30, 2014 | 21,106.00 |
| Mar 31, 2014 | 57,894.00 |
| Dec 31, 2013 | 117,184.00 |
| Sep 30, 2013 | -3,613.00 |
| Jun 30, 2013 | 12,410.00 |
| Mar 31, 2013 | -2,981.00 |
| Dec 31, 2012 | -1,653.00 |
| Sep 30, 2012 | 1,950.00 |
| Jun 30, 2012 | 152.00 |
| Mar 31, 2012 | 3,692.00 |
| Dec 31, 2011 | -9,940.00 |
| Sep 30, 2011 | 4,271.00 |
| Jun 30, 2011 | -16,315.00 |
| Mar 31, 2011 | -9,110.00 |